Search alternatives:
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 901 - 920 results of 61,450 for search '(( 50 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((ng decrease) OR (we decrease)) ))', query time: 1.22s Refine Results
  1. 901
    Time allocation may not decrease with price for a non-linear microscopic utility of leisure.

    Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

    Published 2014
    “…Consequently, <i>TA</i> no longer decreases but may even increase with price (A, lower panel). …”
    Save to List
    Saved in:
  2. 902
    Palmitic acid decreases cell migration by increasing RGS2 expression and decreasing SERCA expression

    Palmitic acid decreases cell migration by increasing RGS2 expression and decreasing SERCA expression by Octavio Galindo-Hernandez (10350992)

    Published 2021
    Save to List
    Saved in:
  3. 903
    Demographics and baseline characteristics of the safety population.

    Demographics and baseline characteristics of the safety population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  4. 904
    iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model.

    iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 905
    Grading of stool consistency and diarrhea severity.

    Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  6. 906
    Secondary efficacy endpoints for the modified intent-to-treat population.

    Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  7. 907
    Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population.

    Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  8. 908
    Source data for Fig 1.

    Source data for Fig 1. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  9. 909
    Source data for S1 and S2 Figs.

    Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  10. 910
    Source data for Fig 2.

    Source data for Fig 2. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 911
    Consolidated Standards for Reporting of Trials flow diagram.

    Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  12. 912
    iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model.

    iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  13. 913
    Source data for Fig 3.

    Source data for Fig 3. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  14. 914
    Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate.

    Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  15. 915
    Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population.

    Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  16. 916
    Diarrheal disease severity by treatment group for the modified intent-to-treat population.

    Diarrheal disease severity by treatment group for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 917
    Table5_Mitochondrial DNA mutations can influence the post-implantation development of human mosaic embryos.DOCX

    Table5_Mitochondrial DNA mutations can influence the post-implantation development of human mosaic embryos.DOCX by Akifumi Ijuin (16817115)

    Published 2023
    Save to List
    Saved in:
  18. 918
    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. Positive controls Cisplatin and doxorubicin against gastrointestinal and colorectal malignancies’ adherent monolayers.

    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. Positive controls Cisplatin and doxorubicin against gastrointestinal and colorectal... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Save to List
    Saved in:
  19. 919
    CD107a-, IFNγ- and MIP 1β-producing Vγ9Vδ2 T-cell subsets decrease in HIV+ patients.

    CD107a-, IFNγ- and MIP 1β-producing Vγ9Vδ2 T-cell subsets decrease in HIV+ patients. by Rita Casetti (608635)

    Published 2015
    Save to List
    Saved in:
  20. 920
    The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level.

    The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level. by Kaitao Zhao (3617825)

    Published 2025
    Save to List
    Saved in:

Search Tools: